Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Solvay Renews Quintiles Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Solvay Renews Quintiles Alliance

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Solvay Pharmaceuticals has renewed its clinical development alliance with Quintiles Transnational Corp. for another five years. First signed in 2001, the renewal reflects the success in accelerating development of Solvay’s product portfolio and improving efficiency.

Through the alliance, Solvay has completed three Phase III programs, moved two compounds from Phase II to Phase III earlier than expected, and produced conclusive Phase II data that resulted in the termination of two other programs, freeing resources for other development work.

“Using Quintiles’ global infrastructure and experts as a strategic asset, we’ve advanced projects at a much faster rate than we could have achieved alone, and with greater flexibility,” said Werner Cautreels, chief executive officer of Solvay Pharmaceuticals. “Over the next five years we aim to achieve even higher levels of value in terms of efficiency, speed and cost-savings.”

Quintiles chairman and chief executive officer, Dennis Gillings, Ph.D., CBE, said, “This alliance shows the power of strategic partnering to create a more efficient and flexible drug development platform. Both Solvay and Quintiles are focused on a single goal — moving products efficiently through development and on to patients in need. This renewal demonstrates the progress we’ve made and our shared passion to achieve that goal.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics